• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VOR

VOR

Vor Biopharma Inc.

NASDAQHealthcareBiotechnologyUS

USD13.44

-0.22 (-1.61%)

Rating:B-

Company Profile

CEO

Jean-Paul Kress

IPO Date

2021-02-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$13.66

Prev. Close

$13.66

Day Low

$13.14

Day High

$13.66

52W Low

$3.62

52W High

$65.80

Market Cap

$0.09B

Volume

0.66M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

26.6%

Avg Negative

1.4%

Avg Neutral

72.0%

News Feed

Vor Biopharma, Janssen Team Up To Develop Combination Therapies For Acute Myeloid Leukemia

Benzinga·7/8/2021·↑ positive

Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

GlobeNewsWire·7/8/2021·↑ positive

Vor Biopharma: Targeted Therapies For Transplants

Seeking Alpha·6/30/2021·↑ positive

Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp

GlobeNewsWire·6/11/2021·↑ positive

Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences

GlobeNewsWire·5/25/2021·↑ positive

Vor Reports Fiscal Year 2020 Financial Results

GlobeNewsWire·3/25/2021·↑ positive

Vor Biopharma to Present at the Barclays Global Healthcare Conference

GlobeNewsWire·3/5/2021·↑ positive

Vor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference

GlobeNewsWire·3/1/2021·↑ positive

Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares

GlobeNewsWire·2/9/2021·↑ positive

VOR Stock Price Increased 108.33%: Why It Happened

Pulse2·2/8/2021·↑ positive